JENNIFER AQUINO-BAUTISTA: Open Payments
NPI 1932529047 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 23 payments from 14 companies in 2025. Trend: 2023 $1,216 · 2024 $820 · 2025 $762
Food & beverage: $647Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $155 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Janssen Biotech, Inc. | 4 | $113 |
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
| GlaxoSmithKline, LLC. | 2 | $64 |
| ABBVIE INC. | 3 | $61 |
| PFIZER INC. | 1 | $40 |
| Legend Biotech USA Inc. | 1 | $35 |
| Astellas Pharma US Inc | 1 | $23 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $23 |
Products named: KYPROLIS, TALVEY, DARZALEX, CARVYKTI, CALQUENCE, BLENREP, ELREXFIO, EPKINLY.
Industry payments across CA — which companies pay providers there.
